Clinical implications of molecular alterations in intraductal carcinoma of the prostate.

Authors

null

Benjamin Miron

Fox Chase Cancer Center, Philadelphia, PA

Benjamin Miron , Shuanzeng Wei , Yasmine Baca , Daniel Herchenhorn , Isabela Werneck Cunha , Kevin Kayvan Zarrabi , Jacqueline T Brown , Matthew James Oberley , Chadi Nabhan , Emmanuel S. Antonarakis , Daniel M. Geynisman , Rana R. McKay

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5024)

DOI

10.1200/JCO.2023.41.16_suppl.5024

Abstract #

5024

Poster Bd #

118

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Genitourinary Cancers Symposium

Germline <em>BRCA2</em>, <em>ATM</em> and <em>CHEK2</em> alterations shape somatic mutation landscapes in prostate cancer.

Germline BRCA2, ATM and CHEK2 alterations shape somatic mutation landscapes in prostate cancer.

First Author: Mari Nakazawa

First Author: Joaquin Mateo

First Author: Nicolas Sayegh

First Author: Gennady Bratslavsky